These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36926123)

  • 1. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers.
    Geetha HS; Singh G; Sekar A; Gogtay M; Singh Y; Abraham GM; Trivedi N
    World J Clin Cases; 2023 Feb; 11(6):1287-1298. PubMed ID: 36926123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang.
    Lv XT; Zhu YP; Cheng AG; Jin YX; Ding HB; Wang CY; Zhang SY; Chen GP; Chen QQ; Liu QC
    World J Clin Cases; 2020 Nov; 8(22):5535-5546. PubMed ID: 33344544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
    Narain S; Stefanov DG; Chau AS; Weber AG; Marder G; Kaplan B; Malhotra P; Bloom O; Liu A; Lesser ML; Hajizadeh N;
    Chest; 2021 Mar; 159(3):933-948. PubMed ID: 33075378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Psychosocial Manifestations and Quality of Life With Inflammatory Markers in SARS-CoV-2 Patients: A Study From a Dedicated COVID-19 Tertiary Care Hospital.
    Kumar K; Srivastava S; Meena A; Avasthi RK; Kashyap B
    Cureus; 2023 Jul; 15(7):e42341. PubMed ID: 37621784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Jawed R; Rafaey W; Hassan M; Rasheed U; Khan M; Khan AR
    Cureus; 2020 Aug; 12(8):e10054. PubMed ID: 32999777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.
    De la Cruz-Cano E; Jiménez-González CDC; Díaz-Gandarilla JA; López-Victorio CJ; Escobar-Ramírez A; Uribe-López SA; Huerta-García E; Ayala-Sumuano JT; Morales-García V; Gútierrez-López L; González-Garrido JA
    F1000Res; 2022; 11():10. PubMed ID: 35464048
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
    Liu SP; Zhang Q; Wang W; Zhang M; Liu C; Xiao X; Liu Z; Hu WM; Jin P
    Diabetes Res Clin Pract; 2020 Sep; 167():108338. PubMed ID: 32712122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
    Shakeeb N; Varkey P; Hynse A; Mandlecha A
    Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study.
    Chikkahonnaiah P; Dallavalasa S; Tulimilli SV; Dubey M; Byrappa SH; Amachawadi RG; Madhunapantula SV; Veeranna RP
    Diseases; 2024 Jul; 12(7):. PubMed ID: 39057114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.
    Nagdev G; Chavan G; Gadkari C; Sahu G
    Cureus; 2022 Oct; 14(10):e30895. PubMed ID: 36465737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease?
    Shanmugavel Geetha H; Prabhu S; Sekar A; Gogtay M; Singh Y; Mishra AK; Abraham GM; Martin S
    World J Virol; 2023 Dec; 12(5):286-295. PubMed ID: 38187498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.